APAXEN
NOVEL THERAPEUTIC DRUGS THAT INHIBIT NLRP3 INFLAMMASOMES TO TREAT INFLAMMATORY DISEASES, WITH A PRIMARY FOCUS ON PULMONARY ARTERIAL HYPERTENSION (PAH)
It seems we can’t find what you’re looking for. Perhaps searching can help.